Is regional citrate superior to systemic heparin anticoagulation for continuous renal replacement therapy? A prospective observational study in an adult regional critical care system.
about
Clinical review: use of renal replacement therapies in special groups of ICU patientsClinical review: Patency of the circuit in continuous renal replacement therapyPlatelet Consumption and Filter Clotting Using Two Different Membrane Sizes during Continuous Venovenous Haemodiafiltration in the Intensive Care Unit.Savoring every drop - vampire or mosquito?The benefit of specialized team approaches in patients with acute kidney injury undergoing continuous renal replacement therapy: propensity score matched analysis.Citrate anticoagulation versus systemic heparinisation in continuous venovenous hemofiltration in critically ill patients with acute kidney injury: a multi-center randomized clinical trial.Anticoagulation, delivered dose and outcomes in CRRT: The program to improve care in acute renal disease (PICARD).Prognosis for long-term survival and renal recovery in critically ill patients with severe acute renal failure: a population-based study.Regional anticoagulation with citrate is superior to systemic anticoagulation with heparin in critically ill patients undergoing continuous venovenous hemodiafiltrationCitrate Pharmacokinetics in Critically Ill Patients with Acute Kidney InjuryQuality indicators of continuous renal replacement therapy (CRRT) care in critically ill patients: a systematic review.Carbon dioxide dialysis in a swine model utilizing systemic and regional anticoagulation.Regional citrate anticoagulation for PrismaFlex continuous renal replacement therapy.Trisodium citrate: an alternative to unfractionated heparin for hemodialysis catheter dwells.Role of citrate and other methods of anticoagulation in patients with severe liver failure requiring continuous renal replacement therapy.Regional citrate anticoagulation for continuous renal replacement therapy in pediatric patients with liver failure.Regional citrate anticoagulation for slow continuous ultrafiltration: risk of severe metabolic alkalosis.Use of High-Flow Continuous Renal Replacement Therapy with Citrate Anticoagulation to Control Intracranial Pressure by Maintaining Hypernatremia in a Patient with Acute Brain Injury and Renal Failure.Citrate anticoagulation for continuous renal replacement therapy in critically ill patients: success and limits.Determinants of Calcium Infusion Rate During Continuous Veno-venous Hemofiltration with Regional Citrate Anticoagulation in Critically Ill Patients with Acute Kidney InjuryA target-oriented algorithm for citrate-calcium anticoagulation in clinical practice.The role of nafamostat mesylate in continuous renal replacement therapy among patients at high risk of bleeding.Regional citrate anticoagulation reduces polymorphonuclear cell degranulation in critically ill patients treated with continuous venovenous hemofiltration.Iloprost for additional anticoagulation in continuous renal replacement therapy--a pilot study.Clinical characteristics of sepsis-induced acute kidney injury in patients undergoing continuous renal replacement therapy.Renal replacement therapy in adult and pediatric intensive care : Recommendations by an expert panel from the French Intensive Care Society (SRLF) with the French Society of Anesthesia Intensive Care (SFAR) French Group for Pediatric Intensive Care E
P2860
Q26853350-E14F1755-3E46-4085-B66A-FA56BD5C30CEQ33375906-0FF5C561-E049-49D2-A497-454B9808DAA1Q33415569-473E2019-7FC5-42DC-9836-D41598A36A0FQ33752207-191A3C57-A8C1-47D5-BB8C-7FA54F61DC08Q34092962-9CAB1169-FE2B-4125-89AC-71B6939F6849Q34169048-9CD4D1A0-EA71-411B-AC50-A773F64E0702Q34451757-31DF3061-CE7C-46A7-A21E-DEAA23AAFFB4Q34480863-091AD406-4A1C-4892-94EF-809D34AD52B7Q34665432-9A568134-0548-45FA-94A6-B9A7F9EBC84EQ34792965-A533C421-AD79-4D34-957A-E4F1F15296FDQ36161099-5EF9EF41-164A-49EA-9E8C-78892A314BE4Q36470982-FE036705-5AC5-40E1-AABB-8DE12C47DD26Q37582081-F4CD60AE-50B8-4978-A4D1-2BF2D1A69116Q37802887-790F29FB-BE3A-4AA6-8B02-09EE7FEF6A10Q38463548-27B2B127-9540-48F3-A1A5-FDA19F54E859Q38632428-38B72100-DA3C-4356-A771-64D422CC0582Q39720522-EC63B38B-262E-4E8D-8DAD-EFCFD2E196ADQ41750468-0674D1D6-2D4D-435D-836A-63070DBC9B8CQ42001643-AAA400F7-C8E7-42B0-8036-F929154902C2Q42030808-A12A9EAA-D8D7-45EB-ACD2-263751A44DA9Q45241537-5A202B6B-5B6F-4622-AC11-4A9DEE2A8FE6Q50518800-49A03DCF-1DD4-4502-9EE7-2DA998021099Q50522179-DDA7887A-2443-4C88-B2ED-93A370F19C33Q52926135-770F6D20-E65F-41C7-9D01-390E7F4C4FA9Q55714613-9F6F43CE-9F64-46DE-AB4B-E21F485D9925Q56967935-B027AB10-7953-4BFB-B5B1-7F56F4C0018B
P2860
Is regional citrate superior to systemic heparin anticoagulation for continuous renal replacement therapy? A prospective observational study in an adult regional critical care system.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Is regional citrate superior t ...... regional critical care system.
@en
type
label
Is regional citrate superior t ...... regional critical care system.
@en
prefLabel
Is regional citrate superior t ...... regional critical care system.
@en
P2093
P1476
Is regional citrate superior t ...... regional critical care system.
@en
P2093
Paul J E Boiteau
Sean M Bagshaw
Tomas Godinez-Luna
P304
P356
10.1016/J.JCRC.2005.01.001
P577
2005-06-01T00:00:00Z